Rocky Mountain spotted fever in the United States, 1997-2002

被引:37
作者
Chapman, Alice S.
Murphy, Staci M.
Demma, Linda J.
Holman, Robert C.
Curns, Aaron T.
McQuiston, Jennifer H.
Krebs, John W.
Swerdlow, David L.
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Viral & Rickettsial Zoonoses Branch, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA
[2] Natl Ctr Infect Dis, Off Director, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA
[3] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30333 USA
关键词
spotted fever; Rickettsia; surveillance;
D O I
10.1089/vbz.2006.6.170
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
Rocky Mountain spotted fever (RMSF) is the most commonly reported fatal tick-borne disease in the United States. During 1997-2002, 3,649 cases of RMSF were reported to the Centers for Disease Control and Prevention via the National Electronic Telecommunications System for Surveillance; 2,589 case report forms, providing supplemental information, were also submitted. The average annual RMSF incidence during 1997-2002 was 2.2 cases/million persons. The annual incidence increased during 1997-2002 to a rate of 3.8 cases/million persons in 2002. The incidence was lowest among persons aged < 5 and 10-29 years, and highest among adults aged 60-69 years. The overall case-fatality rate was 1.4%; the rate peaked in 1998 at 2.9% and declined to 0.7% in 2001 and 2002. Children < 5 years of age had a case-fatality rate (5%) that was significantly greater than the rates for age groups < 60 years of age, except for that for 40-49 years of age. Continued national surveillance is needed to assess the effectiveness of prevention efforts and early treatment in decreasing severe morbidity and mortality associated with RMSF.
引用
收藏
页码:170 / 178
页数:9
相关论文
共 24 条
[1]
ABRAMSON JS, 1990, PEDIATRICS, V86, P123
[2]
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[3]
*CDCP, 2003, MMWR-MORBID MORTAL W, V53, P407
[4]
Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P885
[5]
Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P502
[6]
Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: Is there more to learn? [J].
Childs, JE ;
Paddock, CD .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2002, 66 (05) :450-457
[7]
NATIONAL SURVEILLANCE FOR ROCKY-MOUNTAIN-SPOTTED-FEVER, 1981-1992 - EPIDEMIOLOGIC SUMMARY AND EVALUATION OF RISK-FACTORS FOR FATAL OUTCOME [J].
DALTON, MJ ;
CLARKE, MJ ;
HOLMAN, RC ;
KREBS, JW ;
FISHBEIN, DB ;
OLSON, JG ;
CHILDS, JE .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 52 (05) :405-413
[8]
Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002 [J].
Demma, LJ ;
Holman, RC ;
McQuiston, JH ;
Krebs, JW ;
Swerdlow, DL .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (02) :400-409
[9]
ROCKY-MOUNTAIN SPOTTED-FEVER - CLINICAL, LABORATORY, AND EPIDEMIOLOGICAL FEATURES OF 262 CASES [J].
HELMICK, CG ;
BERNARD, KW ;
DANGELO, LJ .
JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (04) :480-488
[10]
Analysis of risk factors for fatal rocky mountain spotted fever: Evidence for superiority of tetracyclines for therapy [J].
Holman, RC ;
Paddock, CD ;
Curns, AT ;
Krebs, JW ;
McQuiston, JH ;
Childs, JE .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (11) :1437-1444